Trinity Biotech Plc (TRIB) Reports Q2 EPS of $0.09
Tweet
Share
E-mailGet Alerts TRIB Hot Sheet
Join SI Premium – FREE
Trinity Biotech Plc (NASDAQ: TRIB) reported Q2 EPS of $0.09, versus $0.10 reported last year. Revenue for the quarter came in at $26.3 million, versus $24.3 million reported last year.
For earnings history and earnings-related data on Trinity Biotech Plc (TRIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
